When a CVS pharmacy is asked to test the health of its customers, they’re often instructed to test a sample of the customer’s saliva.
But in many cases, the test results aren’t enough to provide the information that doctors need to prescribe the product.
According to the Centers for Disease Control and Prevention (CDC), in 2012, one in five CVS pharmacies in the United States did not have a complete set of the bacteria tested.
And that number is expected to rise as more pharmacies come online, as more and more pharmacies test customers’ saliva for CVS’ antibacterial mouthwashes.
CVS, however, maintains that it has been testing its own customers’ products for at least 15 years.
“As long as we’ve been testing our own products, we have been doing so with a complete record,” a spokesperson told the Associated Press.
In fact, the spokesperson told AP that in the past 15 years, CVS had been testing more than 7 million samples of its products.
It’s a practice that is becoming increasingly common in the industry.
The Centers for Medicare and Medicaid Services (CMS) estimates that by 2020, the industry will test nearly a billion products for bacteria.
And the results of the industry’s annual tests are shared publicly by the companies.
In a statement, Cesar Conde, the director of the CDC’s national antibacterial programs, said, “While this is a good start, we still have a long way to go before we can confidently say that all new products are 100 percent safe for people.”
In a press release, CSP said that testing for bacteria on the products is a “necessary step in ensuring that the antibacterial products we use are effective and can be used safely in the marketplace.”
The CDC has since issued guidance on how to test products for CSP, and the CDC is encouraging the industry to follow the CDC guidance.
However, the new rules are far from perfect.
In particular, the rules say that it is a violation of the rules to test for any bacteria that isn’t present in the product and to report a negative test result to the CVS Customer Care team.
“It is a breach of the federal laws that requires people to follow certain guidelines about the handling of their own samples, which are then shared with the CDC for verification,” Conde told the AP.